Cerebrolysin vs Semax
Side-by-side comparison of Cerebrolysin, Semax — mechanism, dosing, half-life, side effects, and research status.
| Attribute | Cerebrolysin Cerebrolysin (Porcine Brain-Derived Neuropeptide Mixture) Cognitive | Semax Semax (Heptapeptide ACTH Analogue) Cognitive |
|---|---|---|
| Basics | ||
| Molecular type | Neuropeptide Mixture | ACTH-Derived Neuropeptide |
| Amino acids | — | 7 |
| Molecular weight | — | 813.9 Da |
| Half-life | Short (hours) | ~minutes (nasal); longer CNS retention |
| Route(s) | Intravenous (IV), Intramuscular | Intranasal, Subcutaneous |
| Mechanism & Research | ||
| Primary mechanism | Cerebrolysin's mechanism is attributed to its low-molecular-weight peptide fraction, which crosses the blood-brain barrier and exerts BDNF-like, NGF-like, and VEGF-like neurotrophic effects. It stimulates neuroplasticity… | Semax's primary mechanism involves upregulation of brain-derived neurotrophic factor (BDNF) — a neurotrophin critical for neuronal survival, synaptic plasticity, and neurogenesis. In animal models, Semax increases BDNF m… |
| Research status | Research Compound | Research Compound |
| Evidence summary | Cerebrolysin has one of the most extensive clinical research programmes of any nootropic compound, with over 100 controlled trials across Alzheimer's disease, stroke, TBI, and vascular dementia. Evidence is mixed across … | Semax has been investigated in Russian clinical research since the 1980s. It has been approved in Russia as a drug for stroke, TBI, and cognitive decline. Western research interest has grown, but large RCTs meeting curre… |
| Protocol & Dosing | ||
| Typical dose | 10–30 mL per session (IV); 5–10 mL IM | 200–600 mcg/day (intranasal) |
| Frequency | Daily for 10–20 day courses | 1–2x daily |
| Duration | 10–20 day IV course, repeated quarterly | 2–4 weeks cycles |
| Timing | Morning | Morning (or morning + midday); avoid evening to prevent sleep disruption |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Not Prohibited | Not Prohibited |
| Deeper reading | ||
| Related peptides | Semax, Dihexa, Selank | Selank, Dihexa, P21 |
| Full profile | Read full Cerebrolysin profile → | Read full Semax profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.